Meeting Banner
Abstract #1500

1H MRSI for in vivo Lactate Detection in Prostate Cancer

Thiele Kobus1, Jack Van Asten1, Alan Wright1, Arend Heerschap1, Tom Scheenen1

1Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

In this study the use of 1H MRSI for the detection of lactate in the prostate was evaluated with the use of a semi-LASER sequence. No convincing lactate signal was detected in patients with highly aggressive prostate cancer. The minimal detectable lactate level was determined and estimated to be around 3 mM.

Keywords

added adiabatic adjusted aggressive agreement anaerobic applied array assessed assessment assumed benign biopsies blinded body brain calculation cancer choline chosen citrate cleared clinical coil combined committee concentration conclude conditions containing contamination coupling dataset described detectable detected detection determine determined developed diffusion done dutch effective either enabling energy ethical evaluated evaluation exam example fits fitted fitting flat frequency grade grid guided highly human hypothetical in vivo informed inspection internal inverted jack lack lactate laser leading like limit lipid lipids literature local lowest malignant mater matrix maximized measured medical metabolites minimal minimize molecule none noted option organ original part patient patients peak perfused phantom placed presence prevents previously produce progression prostate pulses radiologist radiology rapidly reading refocusing remains reporter resolution samples saturate saturation score selected selective semi several shape short shortest sides simulated since slabs smaller software spatial spectra spectrum stay substrates sufficient suppress timings trio truly tumor tumors varies volume waived water whether zero